You have no items in your shopping cart.
On Promotion
Category
Tested Applications
Reactivity
Conjugation
Biologically Active
Featured Product
Search results for: 'recombinant'
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 30.6 KDa. Observed: 38-45 KDa, reducing conditions
Mouse
Arg18-Gly286
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 25.6 KDa. Observed: 30 KDa, reducing conditions
Mouse
Lys29-Trp249
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 12.4 KDa. Observed: 14 KDa, reducing conditions
Human
Thr2-Cys107
C-6His
500 μg, 1 mg, 10 μg, 50 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 66.5 KDa. Observed: 85-120 KDa, reducing conditions
Human
Arg22-Glu378
C-Fc
10 μg, 50 μg, 500 μg, 1 mgBiotin
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 48.6 KDa. Observed: 65-110 KDa, reducing conditions
Human
Ser24-Gln430
C-6His-Avi
20 μg, 100 μgBiotin
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 44.8 KDa. Observed: 50-60 KDa, reducing conditions
Human
Ala134-Leu285
N-Avi-Fc
100 μg, 20 μgBiotin
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 20.1 KDa. Observed: 30-40 KDa, reducing conditions
Human
His19-Ser174
C-Avi-6His
20 μg, 100 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 44.4 KDa. Observed: 55-65 KDa, reducing conditions
Human
His19-Ser174
C-Fc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 18.3 KDa. Observed: 28-40 KDa, reducing conditions
Cynomolgus
His19-Ser174
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 70.2 KDa. Observed: 80-90 KDa, reducing conditions
Human
His29-Ser409
C-Fc
10 μg, 50 μg, 500 μg, 1 mg